The originating document has been archived. We cannot confirm the completeness, accuracy, or currency of the content.
Takhzyro Prices, Coupons, Copay Cards & Patient Assistance
Takhzyro (lanadelumab) is a member of the hereditary angioedema agents drug class and is commonly used for Hereditary Angioedema.
Takhzyro prices
Subcutaneous Solution
300 mg/2 mL Takhzyro subcutaneous solution from $25,404.16 for 2 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 2 milliliters | $12,702.08 | $25,404.16 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Takhzyro Coupons, Copay Cards and Rebates
Takhzyro offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Takhzyro Takeda Patient Support Program
Eligible commercially insured patients may get up to 100% of their out-of-pocket co-pay costs covered, with savings up to $20,000 per year.
- Applies to:
- Takhzyro
- Number of uses:
- Per prescription per calendar year
Form more information phone: 866-888-0660 or Visit website
Patient Assistance & Copay Programs for Takhzyro
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Takeda Patient Support
Eligibility requirements:- Determined case by case
- Based on FPL
- FDA-approved diagnosis
- Must be residing in the US or a US territory, and under the care of a US physician
- Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.
- Takhzyro (lanadelumab) Injection; Subcutaneous
More information please phone: 877-825-3327 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Berinert
Berinert is used to treat acute abdominal, facial, or laryngeal hereditary angioedema (HAE) attacks ...
Kalbitor
Kalbitor injection is used to treat acute attacks of hereditary angioedema (HAE) in patients 12 ...
Orladeyo
Orladeyo (berotralstat) is used to prevent attacks of hereditary angioedema (HAE). Includes ...
Andembry
Andembry is used to prevent attacks of Hereditary Angioedema (HAE) in adults and children 12 years ...
Ruconest
Ruconest is used to treat angioedema attacks in adult and adolescent patients with Hereditary ...
Firazyr
Firazyr is used for hereditary angioedema (HAE) to treat acute HAE attacks in adults 18 years and ...
Haegarda
Haegarda is an injectable protein replacement therapy that prevents swelling and attacks in ...
Cinryze
Cinryze (complement C1 esterase inhibitor) is used to prevent attacks of angioedema in people with ...
Stanozolol
Stanozolol is used in the treatment of hereditary angioedema, which causes episodes of swelling of ...
More about Takhzyro (lanadelumab)
- Takhzyro consumer information
- Check interactions
- Compare alternatives
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: hereditary angioedema agents
- Breastfeeding
- En español